140 related articles for article (PubMed ID: 17004270)
81. Crystal structures of tRNA-guanine transglycosylase (TGT) in complex with novel and potent inhibitors unravel pronounced induced-fit adaptations and suggest dimer formation upon substrate binding.
Stengl B; Meyer EA; Heine A; Brenk R; Diederich F; Klebe G
J Mol Biol; 2007 Jul; 370(3):492-511. PubMed ID: 17524419
[TBL] [Abstract][Full Text] [Related]
82. Emerging bacterial enzyme targets.
Su Z; Honek JF
Curr Opin Investig Drugs; 2007 Feb; 8(2):140-9. PubMed ID: 17328230
[TBL] [Abstract][Full Text] [Related]
83. Pharmacophore modelling of 17beta-HSD1 enzyme based on active inhibitors and enzyme structure.
Karkola S; Alho-Richmond S; Wahala K
Mol Cell Endocrinol; 2009 Mar; 301(1-2):225-8. PubMed ID: 18822344
[TBL] [Abstract][Full Text] [Related]
84. Macromolecular crystal data phased by negative-stained electron-microscopy reconstructions.
Trapani S; Schoehn G; Navaza J; Abergel C
Acta Crystallogr D Biol Crystallogr; 2010 May; 66(Pt 5):514-21. PubMed ID: 20445226
[TBL] [Abstract][Full Text] [Related]
85. Designing Irreversible Inhibitors--Worth the Effort?
González-Bello C
ChemMedChem; 2016 Jan; 11(1):22-30. PubMed ID: 26593241
[TBL] [Abstract][Full Text] [Related]
86. A new potent inhibitor of fungal melanin biosynthesis identified through combinatorial chemistry.
Jennings LD; Wawrzak Z; Amorose D; Schwartz RS; Jordan DB
Bioorg Med Chem Lett; 1999 Sep; 9(17):2509-14. PubMed ID: 10498198
[TBL] [Abstract][Full Text] [Related]
87. Hierarchical virtual screening for the discovery of new molecular scaffolds in antibacterial hit identification.
Ballester PJ; Mangold M; Howard NI; Robinson RL; Abell C; Blumberger J; Mitchell JB
J R Soc Interface; 2012 Dec; 9(77):3196-207. PubMed ID: 22933186
[TBL] [Abstract][Full Text] [Related]
88. Orphan enzymes could be an unexplored reservoir of new drug targets.
Lespinet O; Labedan B
Drug Discov Today; 2006 Apr; 11(7-8):300-5. PubMed ID: 16580971
[TBL] [Abstract][Full Text] [Related]
89. Mycobacterial crypto-AcpM as a tool to investigate the consequence of drug binding on its key FAS II partner enzyme HadAB.
Singh BK; Biswas R; Basak A; Das AK
Biochim Biophys Acta Gen Subj; 2021 Oct; 1865(10):129964. PubMed ID: 34252514
[TBL] [Abstract][Full Text] [Related]
90. Vinyl fluoride as an isoelectronic replacement for an enolate anion: inhibition of type II dehydroquinases.
Frederickson M; Coggins JR; Abell C
Chem Commun (Camb); 2002 Sep; (17):1886-7. PubMed ID: 12271658
[TBL] [Abstract][Full Text] [Related]
91. Riboflavin analogs and inhibitors of riboflavin biosynthesis.
Mack M; Grill S
Appl Microbiol Biotechnol; 2006 Jul; 71(3):265-75. PubMed ID: 16607521
[TBL] [Abstract][Full Text] [Related]
92. Self-Immolation of a Bacterial Dehydratase Enzyme by its Epoxide Product.
Lence E; Maneiro M; Sanz-Gaitero M; van Raaij MJ; Thompson P; Hawkins AR; González-Bello C
Chemistry; 2020 Jun; 26(36):8035-8044. PubMed ID: 32259333
[TBL] [Abstract][Full Text] [Related]
93. Theoretical evidence of the existence of a diazafulvene intermediate in the reaction pathway of imidazoleglycerol phosphate dehydratase: design of a novel and potent heterocycle structure for the inhibitor on the basis of the electronic structure-activity relationship study.
Gohda K; Kimura Y; Mori I; Ohta D; Kikuchi T
Biochim Biophys Acta; 1998 Jun; 1385(1):107-14. PubMed ID: 9630553
[TBL] [Abstract][Full Text] [Related]
94. Mechanistic studies on type I and type II dehydroquinase with (6R)- and (6S)-6-fluoro-3-dehydroquinic acids.
Parker EJ; González Bello C; Coggins JR; Hawkins AR; Abell C
Bioorg Med Chem Lett; 2000 Feb; 10(3):231-4. PubMed ID: 10698442
[TBL] [Abstract][Full Text] [Related]
95. Discovery of imidazole glycerol phosphate dehydratase inhibitors through 3-D database searching.
Schweitzer BA; Loida PJ; CaJacob CA; Chott RC; Collantes EM; Hegde SG; Mosier PD; Profeta S
Bioorg Med Chem Lett; 2002 Jul; 12(13):1743-6. PubMed ID: 12067551
[TBL] [Abstract][Full Text] [Related]
96. Letter: Dehydroquinase catalyzed dehydration. II. Identification of the reactive conformation of the substrate responsible for syn elimination.
Vaz AD; Butler JR; Nugent MJ
J Am Chem Soc; 1975 Oct; 97(20):5914-5. PubMed ID: 1159247
[No Abstract] [Full Text] [Related]
97. [Effect of several antibiotics on bacterial dehydrases and fumarase].
JACOBSOHN KP; AZEVEDO MD
C R Seances Soc Biol Fil; 1954 Oct; 148(19-20):1712-4. PubMed ID: 14365002
[No Abstract] [Full Text] [Related]
98. Selective Inhibition of Type II Dehydroquinases.
Frederickson M; Parker EJ; Hawkins AR; Coggins JR; Abell C
J Org Chem; 1999 Apr; 64(8):2612-2613. PubMed ID: 11674325
[No Abstract] [Full Text] [Related]
99. Metatranscriptomic Analyses Reveal the Functional Role of
Hegyi ÁI; Otto M; Geml J; Hegyi-Kaló J; Kun J; Gyenesei A; Pierneef R; Váczy KZ
J Fungi (Basel); 2022 Apr; 8(4):. PubMed ID: 35448609
[No Abstract] [Full Text] [Related]
100. Molecular modeling of a series of dehydroquinate dehydratase type II inhibitors of Mycobacterium tuberculosis and design of new binders.
Miranda PHS; Lourenço EMG; Morais AMS; de Oliveira PIC; Silverio PSSN; Jordão AK; Barbosa EG
Mol Divers; 2021 Feb; 25(1):1-12. PubMed ID: 31820222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
